Newly diagnosed with mantle cell lymphoma?
Hearing the words "Mantle Cell Lymphoma" can feel overwhelming. Take a breath — you do not need to understand everything today. Treatment for MCL has changed dramatically in recent years. There is real reason for hope, and you are in the right place.
Seven steps to orient yourself after an MCL diagnosis
A calm starting point — not a comprehensive textbook. Each step links to a dedicated section with deeper information, expert videos, and trusted resources.
Understand your diagnosis
Learn the basics of MCL: how it is diagnosed, staging, and the disease features your care team will discuss.
Learn about MCL →Understand your key tests
Pathology review, TP53, Ki-67, genetic testing, and imaging — and what each one tells your doctors.
Important tests →Find an MCL specialist
MCL is rare. Consulting a doctor who specialises in it — even once — can meaningfully shape your care plan.
Find an MCL expert →Learn about treatment options
Targeted therapies, immunotherapy, chemotherapy, CAR-T, bispecifics, and trials — the landscape is evolving fast.
Explore treatment options →Consider clinical trials
Trials drive progress in rare cancers and can offer access to promising therapies before they are widely available.
Clinical trials →Build your support system
Caregivers, peer communities, and educational events. You do not have to face this alone.
Support & community →Explore the resource library
Educational guides, webinars with MCL experts, patient stories, and practical tools for navigating treatment.
Resource library →Start with trusted, up-to-date information
Three resources we recommend to almost every newly diagnosed patient and caregiver.
NCCN Guidelines for Patients®: Mantle Cell Lymphoma 2025
A 56-page plain-language guide produced by the National Comprehensive Cancer Network® — a not-for-profit alliance of 34 leading cancer centres devoted to patient care, research, and education.
Videos Worth Watching
Understanding your pathology report
After a biopsy confirms MCL, your doctor will receive a pathology report. The terminology can feel confusing — understanding a few key elements will help you feel more confident in conversations with your care team.
Confirming Mantle Cell Lymphoma
Most MCL diagnoses are confirmed through a lymph node biopsy or tissue sample. Pathologists examine the sample under a microscope and run specialised testing for features unique to MCL. A hallmark of MCL is a genetic change involving the cyclin D1 gene, often caused by a chromosomal translocation known as t(11;14). This finding distinguishes MCL from other types of lymphoma.
Ki-67 proliferation index
Ki-67 measures how quickly lymphoma cells are dividing. A higher percentage generally indicates more rapidly growing disease. Your doctor may weigh this when considering treatment options.
TP53 mutation
TP53 is a gene that helps regulate how cells repair damage. When the gene is altered, lymphoma may behave more aggressively and respond differently to certain treatments. TP53 testing has become increasingly important in guiding treatment decisions.
MCL variants
Your report may describe the appearance of the lymphoma cells under a microscope. Some variants include:
- Classic MCL — the most common form.
- Blastoid variant — often grows faster than classic MCL.
- Pleomorphic variant — also considered more aggressive.
These descriptions help doctors anticipate how the disease may behave.
Indolent vs. nodal MCL
MCL can behave very differently from patient to patient. Indolent (leukemic, non-nodal) MCL tends to grow slowly and may not require immediate treatment. Nodal MCL is typically more aggressive and is often treated sooner. Ask your oncologist which pattern best describes your disease.
Staging
After diagnosis, tests such as PET scans, CT scans, or bone marrow biopsies help determine how widely the lymphoma has spread. Staging typically ranges from Stage I (limited to one area) to Stage IV (found in multiple sites including lymph nodes, bone marrow, blood, or organs). Most people with MCL are diagnosed at a later stage — but stage alone does not determine prognosis or treatment. Symptoms, Ki-67, TP53 status, and overall health are often just as important.
When to consider a second pathology review
Because MCL is rare, some patients choose to have their biopsy reviewed by a pathologist who specialises in lymphomas at a major cancer centre. This provides additional confidence in the diagnosis and ensures that all important markers have been evaluated.
Questions you may want to ask
- What subtype of MCL do I have?
- What is my Ki-67 score?
- Was TP53 testing performed? What did it show?
- Is my disease considered indolent or nodal?
- Should my biopsy be reviewed by a lymphoma specialist?
What your first oncology appointment may be like
The first visit is usually focused on understanding your diagnosis and discussing possible next steps — not on making every decision at once.
Preparing for your first visit
Meeting with an oncologist after a cancer diagnosis can feel overwhelming. Many patients worry about what questions to ask, what decisions will be required, and what the future may hold. Give yourself permission to arrive with questions — not answers.
What typically happens during the appointment
Your doctor will usually begin by reviewing:
- Your medical history
- The biopsy results
- Imaging scans
- Laboratory tests
They may perform a physical exam and discuss any symptoms. During the visit, your oncologist may explain the type of MCL you have, whether treatment is recommended now or later, potential treatment options, and any additional testing that may be needed. Not all decisions need to be made during the first appointment.
Bringing support
Many patients find it helpful to bring someone with them. A caregiver, spouse, family member, or friend can help take notes, remember information, and ask questions you may not think of in the moment. Two sets of ears can be incredibly helpful.
Questions you may consider asking
- Do I need treatment right away?
- What treatment options are available?
- Should I consider a second opinion?
- Are clinical trials available for my situation?
- What is the best way to reach the care team between visits?
It is normal to leave the appointment with more questions than answers. That is part of the process.
You do not have to face this alone
Many patients and caregivers find it invaluable to connect with others who understand what they're going through. Online MCL communities offer support, practical guidance, and a place to ask questions — some are even organised by treatment centre or location.
Find an MCL community →Trusted nonprofits that serve the broader blood cancer community
These organisations offer excellent resources beyond what MCLA publishes — and we work alongside many of them.
If you are newly diagnosed with Mantle Cell Lymphoma, you may feel frightened, uncertain, or overwhelmed. Those feelings are normal. But there is also reason for hope.
In recent years, treatment advances for MCL have transformed what is possible, and research continues to move the field forward.
Take things one step at a time. And know that a community of patients, caregivers, doctors, and researchers is working every day to improve outcomes for people living with this disease.